On April 24, 2023 Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will report first quarter 2023 financial results after the close of the U.S. financial markets on Thursday, May 4, 2023, and will hold a conference call at 4:30 p.m. Eastern Time that same day to discuss financial results and provide a general business update (Press release, Ligand, APR 24, 2023, View Source [SID1234630440]). Speakers on the call will include Ligand’s CEO Todd Davis, President and COO Matt Korenberg, and CFO Tavo Espinoza.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call and Webcast Information

Date:

Thursday, May 4, 2023

Time:

4:30 p.m. Eastern time (1:30 p.m. Pacific time)

Conference Call:

(888) 350-3452 (U.S. toll-free number)

1 (646) 960-0369 (ex-U.S. toll dial-in number)

Conference ID is 6501694

Webcast:

Live and replay webcasts of the call are available here.